Jeremy M. Veenstra-VanderWeele, MD

Child and Adolescent Psychiatry
Psychiatry
More specialties
Treats Children
Profile Headshot

Overview

Jeremy Veenstra-VanderWeele, MD, is the William and Joy Ruane Professor of Pediatric Psychopharmacology (in Psychiatry) at Columbia University; Associate Vice Chair and Director of the Division of Child & Adolescent Psychiatry and Developmental Sciences at NewYork-Presbyterian/Morgan Stanley Children’s Hospital, New York State Psychiatric Institute (NYSPI), and Columbia University Irving Medical Center. He is a child and adolescent psychiatrist who uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism spectrum disorder and pediatric obsessive-compulsive disorder.

Dr. Veenstra-VanderWeele’s laboratory at Columbia University and NYSPI focuses on the neurotransmitter systems in genetic mouse models with abnormal social or repetitive/compulsive-like behavior. His clinical research program at the NewYork-Presbyterian Hospital Center for Autism and the Developing Brain studies potential interventions in autism spectrum disorder and related genetic syndromes. Dr. Veenstra-VanderWeele’s work has been recognized with multiple awards, including the 2017 Blanche Ittelson Award for Research in Child and Adolescent Psychiatry from the American Psychiatric Association.

In addition to his research and clinical efforts, Dr. Veenstra-VanderWeele is dedicated to helping train and develop the next generation of child psychiatrists and scientists who can generate an improved understanding of childhood neuropsychiatric disorders and deliver new treatments to the clinic. He serves as Co-Director of both the NIMH T32 Postdoctoral Fellowship for Translational Research in Child Psychiatric Disorders and the Whitaker Scholar Program in Developmental Neuropsychiatry at NYSPI/Columbia University Medical Center. He also founded and co-directs the NIMH R25 Shaffer Scholars Program in Child Psychiatry Research, a research track in the child and adolescent psychiatry clinical residency.

Areas of Expertise / Conditions Treated

  • Autism
  • Autism and Pervasive Develop Disorder
  • Autism Spectrum Disorders
  • Pediatric Autism

Academic Appointments

  • William and Joy Ruane Professor of Pediatric Psychopharmacology (in Psychiatry)
  • Professor of Pediatrics

Administrative Titles

  • Co-Director, Whitaker Scholar Program in Developmental Neuropsychiatry
  • Co-Director, NIMH R25 Shaffer Scholars Program in Child Psychiatry Research
  • Co-Director, NIMH T32 Postdoctoral Fellowship for Translational Research in Child Psychiatric Disorders

Hospital Affiliations

  • NewYork-Presbyterian Komansky Children's Hospital
  • NewYork-Presbyterian Morgan Stanley Children's Hospital
  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian / Weill Cornell Medical Center
  • NewYork-Presbyterian Westchester Behavioral Health

Gender

  • Male

Schedule an Appointment

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Insurance Accepted

Aetna

  • NYP Employee Plan

UnitedHealthcare

  • Behavioral Health (Columbia University Employee Plan)

World Trade Center Health Plan

  • World Trade Center Health Plan

*Before your appointment, please contact the doctor’s office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.

Credentials & Experience

Education & Training

  • MD, 2001 Pritzker School of Medicine at the University of Chicago
  • Residency: University of Chicago Hospitals
  • Fellowship: University of Chicago Hospitals
  • Fellowship: University of Chicago Hospital & Clinics

Board Certifications

  • Psychiatry
  • Child and Adolescent Psychiatry

Research

The Veenstra-VanderWeele lab is dedicated to helping children with autism spectrum disorder (ASD) or obsessive compulsive disorder (OCD) and their families. We are approaching this goal using a variety of techniques, from animal models to research in adults with ASD. The majority of our efforts go toward developing and studying mouse models to understand the relationship between ASD or OCD risk factors and the resulting changes in brain and behavior. We are also working to translate laboratory research findings into novel treatments for children and adults with autism spectrum disorders or related genetic syndromes.

Research Interests

  • Autism Spectrum Disorder (ASD)
  • Obsessive Compulsive Disorder (OCD)

Selected Publications

  • Fernandes, D.J., Ellegood, J., Askalan, R., Blakely, R.D., Dicicco-Bloom, E., Egan, S.E., … Lerch, J.P. (2017). Spatial gene expression analysis of neuroanatomical differences in mouse models. NeuroImage, 163, 220-230. doi: 10.1016/j.neuroimage.2017.08.065
  • Muller, C.L., Anacker, A.M.J., Rogers, T.D., Goeden, N., Keller, E.H., Forsberg, C.G., … Veenstra-VanderWeele, J. (2017). Impact of maternal serotonin transporter genotype on placental serotonin, fetal forebrain serotonin, and neurodevelopment. Neuropsychopharmacology, 42(2), 427-436. doi: 10.1038/npp.2016.166
  • Anagnostou, E., Aman, M.G., Handen, B.L., Sanders, K.B., Shui, A., Hollway, J.A., … Veenstra-VanderWeele, J. (2016). Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: A randomized clinical trial. JAMA Psychiatry, 73(9), 928-937. doi: 10.1001/jamapsychiatry.2016.123
  • Muller, C.L., Anacker, A.M.J., & Veenstra-VanderWeele, J. (2016). The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience, 321, 24-41. doi: 10.1016/j.neuroscience.2015.11.010
  • Veenstra-VanderWeele, J., & Warren, Z. (2015). Intervention in the context of development: pathways toward new treatments. Neuropsychopharmacology, 40, 225-237.
  • Erickson, C.A., Veenstra-VanderWeele, J., Melmed, R.D., McCracken, J.T., Ginsberg, L., Sikich, L., … King, B.H. (2014). STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study. Journal of Autism and Developmental Disorders, 44, 958-964.
  • Dove, D., Warren, Z., Taylor, J.L., Sathe, N., McPheeters, M.L., & Veenstra-VanderWeele, J. (2012). Medication treatments for adolescents and young adults with autism spectrum disorders: A systematic review. Pediatrics, 130, 717-726.
  • Hammock, E.A., Veenstra-VanderWeele, J., Yan, Z., Kerr, T.M., Morris, M., Anderson, G.M., … Jacob, S. (2012). Examining autism spectrum disorders by biomarkers: Example from the oxytocin and serotonin systems. Journal of the American Academy of Child and Adolescent Psychiatry, 51, 712-721.
  • Veenstra-VanderWeele, J., Muller, C.L., Iwamoto, H., Sauer, J.E., Owens, W.A., Cohen, J., … Blakely, R.D. (2012). Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment, and repetitive behavior. Proceedings of the National Academy of Sciences USA, 109, 5469-5474.
Back to top